Estrogen receptor (degrader) drugs for HR+/HER2- Metastatic Breast Cancer
2 tracked Estrogen receptor (degrader) drugs in the HR+/HER2- Metastatic Breast Cancer race. The class explanation lives on the Estrogen receptor (degrader) page; the full indication pipeline across every mechanism is on the HR+/HER2- Metastatic Breast Cancer page.
1 Phase 31 Phase 1/2